Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug Medical Dialogues Bureau5 Jun 2019 6:57 AM GMTHyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleging that Natco Pharma and its US partner Syneos...
Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension Farhat Nasim5 Jun 2019 4:30 AM GMTBosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 9:09 AM GMTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 11:42 AM GMTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules Farhat Nasim28 May 2019 4:30 AM GMTThe approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine Farhat Nasim22 May 2019 4:15 AM GMTAzacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets Farhat Nasim8 May 2019 4:45 AM GMTNitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood...
Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution Farhat Nasim2 May 2019 10:34 AM GMTOlopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets Medical Dialogues Bureau26 April 2019 3:29 AM GMTPhentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
Indoco Remedies: USFDA retains OAI status for Goa plant Farhat Nasim25 April 2019 4:20 AM GMTIndoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution Farhat Nasim15 April 2019 4:35 AM GMTBimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
USFDA inspected Goa facility, no observations issued: Indoco Remedies Farhat Nasim30 March 2019 6:22 AM GMTThe US Food and Drug Administration (USFDA) has cleared the Goa-based sterile manufacturing facility of Indoco Remedies for finished dosages.New...
